Drug Profile
Estrogen receptor beta agonist - Bayer Healthcare Pharmaceuticals
Alternative Names: ERβ agonistLatest Information Update: 21 Mar 2011
Price :
$50
*
At a glance
- Originator Bayer Schering Pharma
- Developer Bayer HealthCare Pharmaceuticals
- Class
- Mechanism of Action Estrogen receptor beta agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Menopausal syndrome
Most Recent Events
- 01 Mar 2011 Bayer Schering Pharma is now called Bayer Healthcare Pharmaceuticals